Correlation Between Denali Therapeutics and MiMedx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and MiMedx Group, you can compare the effects of market volatilities on Denali Therapeutics and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and MiMedx.

Diversification Opportunities for Denali Therapeutics and MiMedx

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Denali and MiMedx is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and MiMedx go up and down completely randomly.

Pair Corralation between Denali Therapeutics and MiMedx

Given the investment horizon of 90 days Denali Therapeutics is expected to generate 2.63 times more return on investment than MiMedx. However, Denali Therapeutics is 2.63 times more volatile than MiMedx Group. It trades about 0.17 of its potential returns per unit of risk. MiMedx Group is currently generating about -0.19 per unit of risk. If you would invest  2,038  in Denali Therapeutics on November 1, 2024 and sell it today you would earn a total of  320.00  from holding Denali Therapeutics or generate 15.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Denali Therapeutics  vs.  MiMedx Group

 Performance 
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's essential indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
MiMedx Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Denali Therapeutics and MiMedx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Denali Therapeutics and MiMedx

The main advantage of trading using opposite Denali Therapeutics and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.
The idea behind Denali Therapeutics and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges